Ocular penetration kinetics of fosfomycin administered as a one-hour infusion

European Journal of Ophthalmology

Volumn 6, Issue 2, 1996, Pages 137-142

  Forestier, F ^a   Salvanet Bouccara, A ^a   Leveques, D ^b   Junes, P ^a   Rakotondrainy, C ^a   Dublanchet, A ^a   Jehl, F ^b  

^a Villeneuve Saint Georges Hospital   (France)

^b Institute of Bacteriology   (France)

Author keywords

Endophthalmitis; Fosfomycin; HPCE; Pharmacokinetics

Indexed keywords

FOSFOMYCIN;

ADULT; AQUEOUS HUMOR; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG PENETRATION; DRUG TISSUE LEVEL; ELECTROPHORESIS; ENDOPHTHALMITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 0030016395     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219600600207     Document Type: Article

References (17)

1. Leveque D, Gallion C, Tarral E, Monteil H, Jehl F. Determination of fosfomycin in human biological fluids by capillary electrophoresis (HPCE). J Chromatogr 1994; 65, 5: 321-4.
2. Braunwald E. Clinical manifestations of heart failure. Functional classification. In: Heart Disease. Philadelphia. W.B. Saunders Company 1988; 496.
3. Salvanet-Bouccara A, Forestier F, Coscas G, Adenis JP. Denis F. Endophthalmies bactériennes: résultats ophthalmologiques d'une enquête prospective multicentrique nationale. J Fr Ophtalmol 1992; (15), 12: 679-82.
4. Salvanet-Douccara A, Dubayle P, Forestier F, Lafaix C, Haroche G. Vers une stratégie raisonnée des endophthalmies bactériennes post-opératoires. J Fr Ophtalmol 1986; 8-8: 523-32.
5. Drugeon H, Baron D, Chung Courtieu AL. The resistance to fosfomycin by mutation A study in vitro. Clinical consequences. Drugs Exp Clin Res 1980; 6: 345-9.
6. Adenis JP, Franco JL. Pénétration intraoculaire des antibiotiques. J Fr Ophtalmol 1987; 12: 789-97.
7. Alvarel S, Jones M, Berk SL. In vitro activity of fosfomycin alone and in combination, against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1985; 28: 689-90.
8. Salvanet-Bouccara A, Feys J, Koffi-Gue B, Fisch A, Cherifi M, Forestier F. Endophtalmies bactériennes: traitement par l'association Fosfocine-Pefloxacine. Bull Soc Ophtalmol France 1989; 11: 1281-5.
9. Adenis JP, Denis F, Franco JL, Mounier M. Etude de la pénétration intraoculaire de la Fosfomycine chez l'homme et chez le lapin. J Fr Ophtalmol 1986; 8-9: 533-7.
10. Radda TM, Gnad HD, Aroussis P. Fosfomycin levels in human aqueous humour after intravenous administration. Arzneim Forsch/Drug Res 1985; 35 (II): 8: 1329-31.
11. Ziak E, Schuhmann G, Konstantinou D, Steinort D. Levels in aqueous humour of eight relevant antibiotics in humans. In: Ishigami J. Recent advances in chemotherapy. Kyoto 1985; 681-3.
12. Keren G, Alhalel A, Bartov E, et al. The intravitreal penetration of orally administered ciprofloxacin in humans. Invest Ophthalmol Vis Sci 1991; 32: 2388-92.
13. Salhi A. Activité bactériostatique in vitro de la fosfomycine: etude préliminaire multicentre avant tout usage thérapeutique en France. Med Mal Infect 1978; 8 (12): 677-84.
14. Potel G, Meignier M, Baron D, Reynaud A, Touze MD, Courtieur AL. Pharmacokinetics of fosfomycin in normal and burn patients. Effect of probenicid. Drugs Exp Clin Res 1989; 15 (4): 177-84
15. Kirby WMM. Pharmacokinetics of fosfomycin. Chemotherapy 1977; 23: 141-51.
16. Goto M, Sugiyama M, Nakagima S, Yamashina M. Fosfomycin kinetics after intravenous and oral administration to human volunteers. Antimicrob Agents Chemoter 1981; 11: 393-7.
17. Portier H, Tremeaux JL, Chavanet P, Gauyot JB, Duez JM, Kazmierczak A. Treatment of severe staphylococcal infections with cefotaxime and fosfomycin in combination. J Antimicrob Chemother 1984; 14 (suppl B): 277-87.